ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,131 | -21.4% | 553,377 | -2.0% | 0.01% | -16.7% |
| Q2 2023 | $2,112,247 | -0.3% | 564,772 | -10.7% | 0.01% | -7.7% |
| Q1 2023 | $2,117,971 | -11.8% | 632,230 | +26.7% | 0.01% | -18.8% |
| Q4 2022 | $2,400,469 | +10.9% | 499,058 | +31.2% | 0.02% | -5.9% |
| Q3 2022 | $2,165,000 | -29.5% | 380,517 | -12.0% | 0.02% | -29.2% |
| Q2 2022 | $3,070,000 | +176.8% | 432,438 | +181.5% | 0.02% | +242.9% |
| Q1 2022 | $1,109,000 | – | 153,605 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |